|
시장보고서
상품코드
2035610
혈액검사 시장 규모, 점유율 및 성장 분석 : 검사 유형별, 최종사용자별, 기술별, 샘플 유형별, 지역별 - 업계 예측(2026-2033년)Blood Testing Market Size, Share, and Growth Analysis, By Testing Type (Clinical Testing, Home Testing), By End User (Hospitals, Clinics), By Technology, By Sample Type, By Region - Industry Forecast 2026-2033 |
||||||
세계의 혈액검사 시장 규모는 2024년에 78억 달러로 평가되었고, 2025년 83억 4,000만 달러에서 2033년까지 142억 2,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 6.9%를 보일 전망입니다.
세계 혈액검사 시장은 정부 및 민간 부문의 의료비 증가에 힘입어 큰 폭의 성장이 예상됩니다. 국제적인 의료 기관들은 만성 질환과 그 관리에 대한 인식을 높이고, 혁신적인 기술을 장려하고 있습니다. 건설적인 규제 프레임워크는 현장진단(POC) 검사의 도입을 촉진하고 있습니다. 만성질환의 유병률 증가와 더불어 건강 평가 도구에 대한 수요 증가가 시장 성장의 원동력이 될 것으로 보입니다. 혈액검사는 질병 모니터링에 있어 매우 중요한 역할을 하기 때문에 업계 관계자들에게 새로운 비즈니스 기회를 창출하고 있습니다. 당뇨병 환자 수가 급증하고 있다는 통계자료를 통해 환자 수가 크게 증가할 것으로 예상되는 가운데, 신뢰할 수 있는 혈액검사 솔루션에 대한 수요가 급증할 것으로 예측됩니다. 규제 당국도 질병의 조기 발견을 돕는 진단 검사의 상용화를 촉진하고 있습니다.
세계 혈액검사 시장의 성장 요인
세계 혈액검사 시장의 성장을 이끄는 주요 요인 중 하나는 혁신적이고 진보된 진단 기술 개발에 초점을 맞춘 임상 연구에 대한 외부 자금의 유입입니다. 이러한 재정적 지원을 통해 연구자와 기업은 연구 방법을 탐구하고 개선할 수 있으며, 이는 궁극적으로 보다 정확하고 효율적인 혈액검사로 이어질 수 있습니다. 결과적으로 이러한 기술의 발전은 환자의 치료 결과를 개선할 뿐만 아니라, 혈액 진단 분야의 지속적인 혁신과 새로운 제품 및 솔루션 도입을 촉진하는 경쟁 환경을 조성하여 시장 확대를 주도하고 있습니다.
세계 혈액검사 시장 성장 억제요인
세계 혈액검사 시장은 인도, 인도네시아, 말레이시아 등 개발도상국 환자들 사이에서 첨단 기술 장비에 대한 인식이 현저히 부족하여 어려움을 겪고 있습니다. 이러한 이해 부족은 혁신적인 혈액검사 방법의 도입을 방해하고, 결과적으로 시장 성장을 제약하고 있습니다. 이들 지역의 의료 시스템은 새로운 기술에 대해 환자를 교육할 수 있는 체계가 충분히 갖추어져 있지 않을 수 있기 때문에 진단 능력 향상의 잠재력을 충분히 활용하지 못하고 있습니다. 그 결과, 이들 지역의 혈액검사 시장의 전반적인 발전을 저해하고 효율적이고 현대적인 의료 솔루션에 대한 접근성을 제한할 수 있습니다.
세계 혈액검사 시장 동향
주요 기업들이 사용자 경험과 진단 정확도를 향상시키기 위해 최첨단 솔루션 개발을 점점 더 우선시함에 따라 세계 혈액검사 시장은 혁신과 기술 발전으로 크게 변화하고 있습니다. 인공지능(AI)과 머신러닝 알고리즘의 통합은 질병의 조기 발견에 혁명을 일으키고 있으며, 의료 서비스 제공업체가 적시에 정확한 결과를 제공할 수 있도록 돕고 있습니다. 또한, 환자 중심의 접근 방식과 보다 접근하기 쉬운 의료에 대한 추진을 배경으로, 현장 검사 및 재택 검사 솔루션에 대한 수요가 증가하고 있습니다. 이러한 추세는 진단 방법의 개선, 나아가 전 세계 환자들의 치료 결과를 개선하기 위한 노력을 상징합니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 혈액검사 시장 규모 : 검사 유형별
세계의 혈액검사 시장 규모 : 최종사용자별
세계의 혈액검사 시장 규모 : 기술별
세계의 혈액검사 시장 규모 : 샘플 유형별
세계의 혈액검사 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.06.01Global Blood Testing Market size was valued at USD 7.8 Billion in 2024 and is poised to grow from USD 8.34 Billion in 2025 to USD 14.22 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The global blood testing market is poised for significant growth driven by increased healthcare expenditure from both government and private sectors. International healthcare organizations are advancing innovative techniques while raising awareness about chronic diseases and their management. Constructive regulatory frameworks are enhancing the adoption of point-of-care (POC) testing. The rising prevalence of chronic illnesses, coupled with heightened demand for health assessment tools, is likely to propel market momentum. As blood testing plays a vital role in disease monitoring, new opportunities are emerging for industry players. With soaring diabetes statistics indicating a substantial rise in affected individuals, the demand for reliable blood testing solutions is expected to surge. Regulatory bodies are also facilitating the commercialization of diagnostic tests that support early disease detection.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Testing Market Segments Analysis
Global Blood Testing Market is segmented by Testing Type, End User, Technology, Sample Type and region. Based on Testing Type, the market is segmented into Clinical Testing and Home Testing. Based on End User, the market is segmented into Hospitals, Clinics and Individuals. Based on Technology, the market is segmented into Conventional Methods and Advanced Technologies. Based on Sample Type, the market is segmented into Blood and Other Bodily Fluids. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Blood Testing Market
One of the key factors propelling the growth of the global blood testing market is the influx of external funding directed towards clinical studies focused on the development of innovative and advanced diagnostic technologies. This financial support enables researchers and companies to explore and enhance testing methodologies, ultimately leading to more accurate and efficient blood tests. As a result, the advancement of these technologies not only improves patient outcomes but also drives market expansion by fostering a competitive environment that encourages continuous innovation and the introduction of new products and solutions in the field of blood diagnostics.
Restraints in the Global Blood Testing Market
The Global Blood Testing market faces challenges due to a significant lack of awareness regarding advanced technological devices among patients in developing nations, including countries like India, Indonesia, and Malaysia. This limited understanding hampers the adoption of innovative blood testing methods, which in turn constrains market growth. As healthcare systems in these regions may not be fully equipped to educate patients about new technologies, the potential for improved diagnostic capabilities remains underutilized. Consequently, the overall development of the blood testing market in these regions could be stifled, limiting access to efficient and modern healthcare solutions.
Market Trends of the Global Blood Testing Market
The global blood testing market is experiencing a significant shift towards innovation and technological advancement, as key players increasingly prioritize the development of cutting-edge solutions to enhance user experience and diagnostic accuracy. The integration of Artificial Intelligence and machine learning algorithms is revolutionizing the early detection of diseases, enabling healthcare providers to deliver timely and precise results. Additionally, the demand for point-of-care testing and home-testing solutions is rising, driven by patient-centric approaches and the push for more accessible healthcare. This trend signifies a commitment to improving diagnostic practices and ultimately enhancing patient outcomes worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Blood Testing Market Size by Testing Type & CAGR (2026-2033)
- Market Overview
- Clinical Testing
- Routine Tests
- Complete Blood Count
- Metabolic Panel
- Diagnostics
- Infectious Disease Testing
- Genetic Testing
- Home Testing
- Self-Testing Kits
- Mobile Testing Devices
Global Blood Testing Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Inpatient Services
- Outpatient Services
- Clinics
- Private Practices
- Specialty Clinics
- Individuals
- Health-Conscious Consumers
- Chronic Condition Patients
Global Blood Testing Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Conventional Methods
- Phlebotomy
- Venipuncture Techniques
- Advanced Technologies
- Point-of-Care Testing
- Lab-on-a-Chip
Global Blood Testing Market Size by Sample Type & CAGR (2026-2033)
- Market Overview
- Blood
- Whole Blood
- Serum
- Other Bodily Fluids
- Plasma
- Saliva Tests
Global Blood Testing Market Size & CAGR (2026-2033)
- North America (Testing Type, End User, Technology, Sample Type)
- US
- Canada
- Europe (Testing Type, End User, Technology, Sample Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Testing Type, End User, Technology, Sample Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Testing Type, End User, Technology, Sample Type)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Testing Type, End User, Technology, Sample Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- LabCorp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioReference Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shionogi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EMD Millipore
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genomic Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cypress Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
